학술논문
CO130 Subgroup Analysis of Quality-of-Life Outcomes in Patients Achieving F-VASI75: Pooled Results from Two Randomized Phase 3 Studies of Ruxolitinib Cream for the Treatment of Vitiligo
Document Type
Abstract
Author
Source
In Value in Health July 2022 25(7) Supplement:S328-S328
Subject
Language
ISSN
1098-3015